VAERS reports by lot

GSK Varicella/Shingles lot KS43H: VAERS reports

21 VAERS reports list lot KS43H as a GSK Varicella/Shingles vaccine, received between 2020-02-21 and 2021-09-23. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
21
Reports
5%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2429%
Neurological1620%
Musculoskeletal1518%
General / Systemic (non-local)1113%
Dermatological (non-injection-site)56%
Gastrointestinal45%
Cardiac / Cardiovascular22%
Respiratory22%
Autoimmune / Immune-mediated11%
Allergic / Anaphylactic11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania3
Virginia3
Ohio3
Maryland2
Connecticut1
Florida1
Nevada1
District of Columbia1
Illinois1
Indiana1
Tennessee1
California1

Reports by month received

2020-021
2020-037
2020-042
2020-051
2020-063
2020-073
2020-083
2021-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.